
William H Grieb
Examiner (ID: 18243)
| Most Active Art Unit | 3304 |
| Art Unit(s) | 3711, 2899, 3304, 2506, 3303, 3727 |
| Total Applications | 2579 |
| Issued Applications | 2436 |
| Pending Applications | 35 |
| Abandoned Applications | 108 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4887706
[patent_doc_number] => 20080262038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Diarylmethylidene Piperidine Derivatives, Preparations Thereof and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/596853
[patent_app_country] => US
[patent_app_date] => 2005-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13549
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262038.pdf
[firstpage_image] =>[orig_patent_app_number] => 10596853
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/596853 | Diarylmethylidene Piperidine Derivatives, Preparations Thereof and Uses Thereof | Jan 4, 2005 | Abandoned |
Array
(
[id] => 7225292
[patent_doc_number] => 20050261334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Bis-pyridino containing compounds for the use in the treatment of CNS pathologies'
[patent_app_type] => utility
[patent_app_number] => 11/027675
[patent_app_country] => US
[patent_app_date] => 2005-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16037
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20050261334.pdf
[firstpage_image] =>[orig_patent_app_number] => 11027675
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/027675 | Bis-pyridino containing compounds for the use in the treatment of CNS pathologies | Jan 2, 2005 | Abandoned |
Array
(
[id] => 4985848
[patent_doc_number] => 20070152186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Reactive oxygen detecting and/or absorbing compound, method for preparing said compound and a device comprising it'
[patent_app_type] => utility
[patent_app_number] => 10/596557
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3458
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20070152186.pdf
[firstpage_image] =>[orig_patent_app_number] => 10596557
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/596557 | Reactive oxygen detecting and/or absorbing compound, method for preparing said compound and a device comprising it | Dec 14, 2004 | Abandoned |
Array
(
[id] => 5178120
[patent_doc_number] => 20070179180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Novel m3 muscarinic acetylcholine receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/581229
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7709
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20070179180.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581229
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581229 | Novel m3 muscarinic acetylcholine receptor antagonists | Dec 2, 2004 | Abandoned |
Array
(
[id] => 5178124
[patent_doc_number] => 20070179184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Novel m3 muscarinic acetylcholine receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/581230
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5642
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20070179184.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581230
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581230 | Novel m3 muscarinic acetylcholine receptor antagonists | Dec 2, 2004 | Abandoned |
Array
(
[id] => 6983909
[patent_doc_number] => 20050153979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Novel piperidine-substituted indoles-or heteroderivatives thereof'
[patent_app_type] => utility
[patent_app_number] => 10/990059
[patent_app_country] => US
[patent_app_date] => 2004-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11058
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153979.pdf
[firstpage_image] =>[orig_patent_app_number] => 10990059
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/990059 | Piperidine-substituted indoles-or heteroderivatives thereof | Nov 15, 2004 | Issued |
Array
(
[id] => 4939480
[patent_doc_number] => 20080076799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Piperidinic Derivatives, Pharmaceutic Compositions Containing the Same and Preparation Processes'
[patent_app_type] => utility
[patent_app_number] => 11/576864
[patent_app_country] => US
[patent_app_date] => 2004-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9595
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076799.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576864
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576864 | Piperidinic derivatives, pharmaceutic compositions containing the same and preparation processes | Oct 14, 2004 | Issued |
Array
(
[id] => 5136537
[patent_doc_number] => 20070078166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3] triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone'
[patent_app_type] => utility
[patent_app_number] => 10/574712
[patent_app_country] => US
[patent_app_date] => 2004-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11634
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20070078166.pdf
[firstpage_image] =>[orig_patent_app_number] => 10574712
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/574712 | Crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone | Oct 11, 2004 | Issued |
Array
(
[id] => 4966000
[patent_doc_number] => 20080108820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Hemiasterlin Derivatives and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/572871
[patent_app_country] => US
[patent_app_date] => 2004-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47994
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108820.pdf
[firstpage_image] =>[orig_patent_app_number] => 10572871
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/572871 | Hemiasterlin Derivatives and Uses Thereof | Sep 21, 2004 | Abandoned |
Array
(
[id] => 74742
[patent_doc_number] => 07750161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-06
[patent_title] => 'Pyridine derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/573516
[patent_app_country] => US
[patent_app_date] => 2004-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23494
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/750/07750161.pdf
[firstpage_image] =>[orig_patent_app_number] => 10573516
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573516 | Pyridine derivatives | Sep 20, 2004 | Issued |
Array
(
[id] => 300031
[patent_doc_number] => 07538233
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-26
[patent_title] => 'Coumarins as iNOS inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/925292
[patent_app_country] => US
[patent_app_date] => 2004-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20038
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/538/07538233.pdf
[firstpage_image] =>[orig_patent_app_number] => 10925292
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/925292 | Coumarins as iNOS inhibitors | Aug 23, 2004 | Issued |
Array
(
[id] => 5732870
[patent_doc_number] => 20060257987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Ppar modulators'
[patent_app_type] => utility
[patent_app_number] => 10/566291
[patent_app_country] => US
[patent_app_date] => 2004-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 119010
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257987.pdf
[firstpage_image] =>[orig_patent_app_number] => 10566291
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/566291 | Ppar modulators | Aug 16, 2004 | Abandoned |
| 10/914460 | Use of fused imidazoles, aminopyrimidines, isonicotinamides, aminomethyl phenoxypiperidines and aryloxypiperidines to promote and detect endogenous neurogenesis | Aug 8, 2004 | Abandoned |
Array
(
[id] => 4772856
[patent_doc_number] => 20080058515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Chemical Compounds'
[patent_app_type] => utility
[patent_app_number] => 10/566040
[patent_app_country] => US
[patent_app_date] => 2004-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17551
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20080058515.pdf
[firstpage_image] =>[orig_patent_app_number] => 10566040
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/566040 | Chemical Compounds | Jul 22, 2004 | Abandoned |
Array
(
[id] => 5035608
[patent_doc_number] => 20070100147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Process for preparing raloxifene hydrochloride'
[patent_app_type] => utility
[patent_app_number] => 10/562762
[patent_app_country] => US
[patent_app_date] => 2004-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2615
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20070100147.pdf
[firstpage_image] =>[orig_patent_app_number] => 10562762
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/562762 | Process for preparing raloxifene hydrochloride | Jun 27, 2004 | Abandoned |
Array
(
[id] => 7011423
[patent_doc_number] => 20050065139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Glycosidase inhibitors and methods of synthesizing same'
[patent_app_type] => utility
[patent_app_number] => 10/877490
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 35227
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20050065139.pdf
[firstpage_image] =>[orig_patent_app_number] => 10877490
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/877490 | Glycosidase inhibitors and methods of synthesizing same | Jun 24, 2004 | Abandoned |
Array
(
[id] => 5890112
[patent_doc_number] => 20060276507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Hydroxamate sulfonamides as cd23 shedding inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/560327
[patent_app_country] => US
[patent_app_date] => 2004-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15539
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276507.pdf
[firstpage_image] =>[orig_patent_app_number] => 10560327
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/560327 | Hydroxamate sulfonamides as cd23 shedding inhibitors | Jun 17, 2004 | Abandoned |
Array
(
[id] => 5016709
[patent_doc_number] => 20070259918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => '2-Hydroxymethyl-3,4,5-Trihydroxy-1-(4-Pentyloxybenzyl) Piperidine as Glucosylceramide Synthase (Gcs) Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 10/560383
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5998
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259918.pdf
[firstpage_image] =>[orig_patent_app_number] => 10560383
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/560383 | 2-hydroxymethy1-3,4,5-trihydroxy-1-(4-pentyloxybenzyl) piperidine as glucosylceramide synthase (Gcs) inhibitor | Jun 8, 2004 | Issued |
Array
(
[id] => 7978065
[patent_doc_number] => 08071780
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => '2-Hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide'
[patent_app_type] => utility
[patent_app_number] => 10/560385
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6527
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071780.pdf
[firstpage_image] =>[orig_patent_app_number] => 10560385
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/560385 | 2-Hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide | Jun 8, 2004 | Issued |
Array
(
[id] => 5107730
[patent_doc_number] => 20070066608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Novel indole derivatives with an improved antipsychotic activity'
[patent_app_type] => utility
[patent_app_number] => 10/556931
[patent_app_country] => US
[patent_app_date] => 2004-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10521
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20070066608.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556931
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556931 | Novel indole derivatives with an improved antipsychotic activity | May 25, 2004 | Abandoned |